New use could give J&J drug edge over Pfizer’s rival
Social Media in Pharma
Committee could not decide if Sutent can be used after the removal of a cancerous kidney.
J&J used anticompetitive tactics to prevent use of cheaper Inflectra
Pharma 2022: big pharma to maintain its position, ready to pounce on any newcomer that shows promise.
Updates on Social Media in Pharma